Market Indices
Latest News
 |
Key Points- Faruqi & Faruqi, LLP reminds Aldeyra Therapeutics investors of...May 26, 2026 ALDX 11.94% |
| ||
| ||
| ||
|
Price Targets
from H.C. Wainwright issued a price target of $43.50 for PPTA on 2026-05-26 13:32:27.The adjusted price target was set to $43.50.At the time of the announcement, PPTA...
May 26, 2026 PPTA 4.11%
Raghuram Selvaraju from H.C. Wainwright issued a price target of $17.00 for BWAY on 2026-05-26 10:15:17.The adjusted price target was set to $17.00.At the time of the announcement,
May 26, 2026 BWAY 5.53%
Edward Nash from Canaccord Genuity issued a price target of $6.00 for CNTB on 2026-05-26 09:23:29.The adjusted price target was set to $6.00.At the time of the announcement,
May 26, 2026 CNTB 1.83%
Chris Zhang from UBS issued a price target of $300.00 for DAVE on 2026-05-26 07:15:00.The adjusted price target was set to $300.00.At the time of the announcement, DAVE...
May 26, 2026 DAVE 8.34%
Manav Gupta from UBS issued a price target of $2.00 for GEVO on 2026-05-22 12:57:41.The adjusted price target was set to $2.00.At the time of the announcement, GEVO...
May 22, 2026 GEVO 0.56%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| VCIG VCI Global Limited | 2.70
103.01% | ||||||||||||||||||
| WGSWW WGSWW | 0.01
29.70% | ||||||||||||||||||
| IPWR Ideal Power Inc. | 7.24
26.35% | ||||||||||||||||||
| RDW Redwire Corporation | 21.97
25.61% | ||||||||||||||||||
| ASPI ASP Isotopes Inc. Common | 6.95
25.23% | ||||||||||||||||||
| MREO Mereo BioPharma Group plc | 0.35
24.25% | ||||||||||||||||||
| DAVEW Dave Inc. Warrants | 0.63
23.53% | ||||||||||||||||||
| LFVN LifeVantage Corporation | 6.78
20.86% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 3.93%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 9.62%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 5.11%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.14%